Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Huntingdon Life Sciences, Inc.
EIR
•Huntingdon Life Sciences, Inc.•January 28, 2011

Huntingdon Life Sciences, Inc. – FDA EIR, Jan 28, 2011

Record Details

An FDA surveillance inspection of Huntingdon Life Sciences, Inc., a non-clinical testing facility in East Millstone, NJ, was conducted from January 13 to January 28, 2011. The inspection assessed compliance with Good Laboratory Practice (GLP) regulations, specifically 21 CFR 58.808. Key areas reviewed included organization, study director responsibilities, quality assurance, facilities, equipment, and study conduct. The inspection resulted in two primary observations documented on an FDA Form 483. First, the facility's ambient pharmacy storage for test and control articles was inadequate, failing to maintain the necessary environmental conditions (e.g., humidity exceeding 40% for "dry place" requirements) to preserve product identity, strength, purity, and stability. Second, a non-clinical laboratory study (HLS Study (b)(4)) was not conducted in full accordance with its approved protocol. Additionally, discussions addressed several other areas. These included inconsistent archival timelines for study data and reports, insufficient detail in Institutional Animal Care and Use Committee (IACUC) meeting minutes regarding protocol discussions, and personnel observed smoking in scrubs and lab coats outside, raising potential contamination risks. Management committed to providing written responses with definitive corrective actions for the formal observations and acknowledged the need for improvements in the other discussed areas. The facility had previously implemented corrections for observations from a 2008 inspection.

Company
Huntingdon Life Sciences, Inc.
Inspection date
January 28, 2011
Product type
drugs
Office
New Jersey District Office
People
  • Denise M. Visco (investigator)
  • Dawn L. Wydner (issuing_officer)
View Company Profile

ID · ad116ead-57fc-4a2a-89d1-f2b3f6b6f020

Violation Codes3
21 CFR 58.130(a)21 CFR 58.47(b)21 CFR 58.47(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Huntingdon Life Sciences, Inc.
  • EIR - 2020-08-14August 14, 2020
  • 483 - 2011-01-28January 28, 2011

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Huntingdon Life Sciences, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.